New research warns daily aspirin use in older adults without heart disease may do more harm than good, increasing bleeding ...

Bayer told workers to self-organize last year as part of a plan to save €2 ... green shoots may finally be appearing following a desperately dark time for the German group that invented aspirin.

Bayer is also trying to convince regulators and investors about its pending agri-business mega-merger ... plus aspirin 100 mg once daily reduced the risk of the composite outcome of stroke, ...

Almost 15 percent of U.S. adults aged 50 to 80 years are taking aspirin for primary cardiovascular disease prevention, ...

Addressing a longstanding controversy in cancer prevention, a large randomized trial showed that low-dose aspirin reduced the risk of colorectal cancer (CRC) in patients with Lynch syndrome just as ...

Bayer HealthCare has introduced Bayer Advanced aspirin, which can relieve pain twice as fast as previous Bayer aspirin tablets, according to the company. Practice Specialties ...

Around 1 in 6 older adults take aspirin as their primary method of preventing cardiovascular disease – despite stricter ...

In the massive trial, which included 6,564 PAD patients in 34 countries, a twice-daily, 2.5-mg dose of Xarelto added to 100 mg per day of aspirin after LER reduced the chance of ischemia by 33% ...

The 6.0 percentage point advantage with placebo was driven by less bleeding, with a relative 34% fewer nonsurgical bleeding events, translating to 14.5 fewer bleeding events per 100 patient-years ...

From the start, Bayer and Huma’s relationship has been a mutually beneficial one, with the Big Pharma Bayer, Huma build online prediction tool for heart disease Fierce Pharma ...